Improving Outcomes of Women’s Reproductive Cancers

Women’s reproductive cancers – such as ovarian and cervical cancer – affect millions worldwide, yet research funding for these cancers has been disproportionately scarce. This event marked the launch of the NYSCF Women’s Reproductive Cancer Initiative, which aims to shift paradigms in the way these cancers are studied and treated, in collaboration with leading cancer experts across the globe.

Dr. Laura Andres-Martin of the NYSCF Research Institute spoke about the new ovarian cancer research program she is launching that leverages the power of stem cell technology to create a living biobank of patient tumor samples. She was joined by a panel of Initiative collaborators (Drs. Ursula Matulonis, Siddhartha Mukherjee, and Carla Grandori), to discuss emerging approaches to women’s reproductive cancer research and the new technologies that are enabling personalized treatment strategies.

Event sponsored by:  

Women's Reproductive Cancers Panel

April 3, 2019 (6:30 – 8:30 pm)

MODERATOR Susan L. Solomon, JD The NYSCF Research Institute

PANELIST Laura Andres-Martin, PhD The NYSCF Research Institute

PANELIST Carla Grandori, MD, PhD SEngine Precision Medicine

PANELIST Ursula Matulonis, MD Chief of Gynecologic Oncology, Dana-Farber Cancer Institute

PANELIST Siddhartha Mukherjee, MD, DPhil Columbia University Irving Medical Center

To learn more about the NYSCF Women’s Reproductive Cancers Initiative, click here.

Support for this event was provided by 

For more information, call Ali Kean at 212.365.7425